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Regulation of cell survival is critical for organ development. Translationally controlled tumor protein (TCTP) is a conserved protein
family implicated in the control of cell survival during normal development and tumorigenesis. Previously, we have identified a
human Topoisomerase II (TOP2) as a TCTP partner, but its role in vivo has been unknown. To determine the significance of this
interaction, we examined their roles in developing Drosophila organs. Top2 RNAi in the wing disc leads to tissue reduction and
caspase activation, indicating the essential role of Top2 for cell survival. Top2 RNAi in the eye disc also causes loss of eye and head
tissues. Tctp RNAi enhances the phenotypes of Top2 RNAi. The depletion of Tctp reduces Top2 levels in the wing disc and vice versa.
Wing size is reduced by Top2 overexpression, implying that proper regulation of Top2 level is important for normal organ
development. The wing phenotype of Tctp RNAi is partially suppressed by Top2 overexpression. This study suggests that mutual
regulation of Tctp and Top2 protein levels is critical for cell survival during organ development.
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INTRODUCTION
TCTP is a growth control protein, initially found as P23 in murine
and human tumor cells [1, 2]. Evolutionarily conserved TCTP family
proteins are involved in diverse biological processes, including
growth, immune response, and cytoskeletal changes [3–6].
Abnormal regulation of TCTP has been implicated in the
pathogenesis of growth-related diseases. Human TCTP is upregu-
lated in various types of cancer cells or tissues [7–9]. Furthermore,
tumors can be reverted by reducing the TCTP function, implying
its critical role in cancer [10, 11].
TCTP is also involved in the regulation of apoptosis [12–17].
Consistent with the anti-apoptotic function of TCTP, its over-
expression can induce chemoresistance to cancer cells or
tissues treated with anti-cancer drugs including etoposide [18–
22]. Since the primary target of etoposide is Topoisomerase II
(TOP2) [23–25], it is an intriguing question whether the anti-
apoptotic function of human TCTP is functionally related
to TOP2.
Top2 cuts double-strand DNA to relax its tangles during
replication and transcription. In vertebrates, there are two
subclasses of type II topoisomerases, TOP2A and TOP2B. An
important biological function of TOP2 is to regulate tissue growth
since top2 mutants in zebrafish and mice show growth defects
[26–28]. Like TCTP, a human TOP2 paralog TOP2A is highly
overexpressed in cancer cells [29–31], and its knockdown
suppresses the invasive capacity of the cancer cells [30, 32, 33].
These findings suggest that TCTP and TOP2 might play similar
roles in growth control. However, it is unknown whether there is a
functional relationship between TCTP and TOP2 in vivo.
Drosophila has been used as a powerful model organism to
study in vivo functions of TCTP. Genetic analysis has shown that
Drosophila TCTP (Tctp) is required for organ development by
regulating TOR signaling [3, 34], cell cycle [4, 35], and cell junctions
[36]. It also regulates DNA damage response [37], tissue home-
ostasis in intestinal stem cells [38], and global gene expression
[39]. These studies indicate that Tctp has a multitude of functions
in different subcellular compartments to regulate growth-related
processes.
Drosophila has only one gene for Top2 that is expressed
throughout development. Top2 is involved in several processes,
including chromosome condensation [40], chromatin remodeling
[41], pairing or separation of chromosomes [42, 43], dosage
compensation [44], and cell cycle regulation [45–47]. Given these
various roles of Top2 during development, Top2 null mutants
show pupal lethality with abnormal growth of larval brain and
imaginal discs [48]. Although Top2 is required for mitosis in the
larval brain [47], specific roles of Top2 in imaginal disc
development have not been characterized.
We initially discovered the human TCTP-TOP2 interaction in a
yeast two-hybrid screen for TCTP binding proteins [17]. In this
study, we investigated the functional relationships between Tctp
and Top2 in Drosophila organ development. Our data suggest that
Tctp and Top2 regulate each other to maintain their levels for cell
survival during organ development.
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MATERIALS AND METHODS
Fly stocks and genetics
Drosophila melanogaster stocks were cultured in a standard cornmeal
medium. Most genetic crosses were carried out at 25 °C unless stated
otherwise. w1118 was used as the wild-type control. GAL4 lines are as
follows: en-GAL4, nub-GAL4, and ey-GAL4. The following lines were from
Bloomington Drosophila Stock Center (BDSC), Vienna Drosophila Resource
Center (VDRC), or National Institute of Genetics (NIG): Top2 RNAi (BDSC
31342, VDRC v30625, v330177, and NIG10223R-2), and UAS-Diap1 (BDSC
6657). Tctp RNAi was described [3]. Top2Suo1 mutant was obtained from Dr.
Silvia Bonaccorsi [47].
Antibodies, immunostaining, and imaging
Imaginal discs were dissected from third instar larvae in cold
phosphate-buffered saline (PBS) (pH 7.4). Samples were fixed in PLP
(2–4% paraformaldehyde, 10 mM sodium periodate, 75 mM lysine, and
35 mM sodium phosphate buffer or PBS, pH 7.4) for 15 min at room
temperature (RT). Discs samples were washed with PBS for 5 min two
times. Samples were treated with blocking buffer (0.3% Triton X-100, 5%
normal goat serum and 0.08% NaN3 in PBS, or 0.3% Triton X-100, 0.5%
BSA, 0.01% NaN3 in PBS) for 2 h at 4 °C or 40 min at RT, and incubated
with primary antibodies diluted in washing buffer (0.3% Triton X-100 in
PBS) overnight at 4 °C. Primary antibodies were: rabbit anti-cleaved
Death caspase-1 (Dcp-1) (Asp216) (Cell Signaling Technology 9578,
1:100), rabbit anti-Top2 (gift from Dr. Donna Arndt-Jovin, 1:2000) [45],
and rabbit anti-Tctp (1:100) [3].
After incubation with primary antibodies, samples were rinsed with
washing buffer for 15min six times and treated with secondary antibodies
(Jackson immune research laboratories,1:200) in washing buffer for 2 h at
RT. Samples were rinsed with washing buffer for 10min six times and PBS
for 5 min two times. For DNA staining, samples were treated with 4,6
Diamidine-2-phenylinddedin (DAPI) (Boehringer Mannheim, Germany) at
1:1000 during the last washing in washing buffer. Samples were mounted
with vectashield (H-1000, Vector Laboratories, USA) and imaged using a
confocal microscope (ZEISS LSM710 or 780). The ZEN program was used
for image analysis.
Adult wings were mounted using a wing mounting solution (1:1 mix of
Canada balsam-sigma C1795 and methyl salicylate-sigma M6725) and
imaged using a light microscope (ZEISS Axio Imager M2) with Axio vision
Rel4.8 program. Adult eye or pupa pictures were taken using a light
microscope (ZEISS KL 1500 LCD Axio cam MRC, stemi 2000-C) with Axio
vision Rel4.8 program.
Western blot
Protein samples were separated in SDS-PAGE gel with electrophoresis
buffer and transferred to the PVDF membrane (Immobilon-P) after 100%
methanol activation. Blots were incubated in a blocking solution contain-
ing 5% skim milk (232100 from BD Difco) or 3–5% BSA (BSA-BSH from
RMBIO) in TBST (10 mM Tris-Cl pH 7.5, 150 mM NaCl, and 0.1% Tween-20)
for 30min at RT. Blots were incubated in the blocking solution containing
primary antibodies at 4 °C overnight. Primary antibodies were: rabbit anti-
Top2 (1:5000) [45], rabbit anti-Tctp (1:2000) [3], and mouse anti-β-Tubulin
(DSHB, E7, 1:10000).
After incubation with primary antibodies, samples were washed for
15min four times using washing buffer TBST, and incubated with
secondary antibodies (Jackson immune research laboratories, 1:10000)
for 1 h at RT, and washed for 15min four times. Membranes were
incubated in ECL solution (Prod #34095, Prod #34080, or Prod #34580,
Thermo Fisher Scientific) and exposed to X-ray film.
S2 cell culture
S2 cell line (from DGRC) was cultured at 24 °C. Complete medium is
composed of serum-free media (Gibco express five SFM, Thermo Fisher
Scientific) with 200 mM L-Glutamine and antibiotics (penicillin and
streptomycin) as described in the Thermo Fisher Scientific protocol.
Transgene construction
A DNA fragment encoding Top2 from pFlc1-Top2 (DGRC RE49802) was
inserted into the pUAST-attB vector for making the pUAST-attB-Top2
construct. According to DGRC, Top2 cDNA has a deletion mutation in
304–364, point nonsense mutation; stop codon in 3802–3601. However,
our analysis detected a deletion mutation at 333, and stop codon at 3817.
Therefore, we corrected these mutations in pFlc1-Top2.
PCR was done using Prime star HS DNA polymerase (Takara, R010A) with
primers. PCR products were separated in 1% agarose gel (Seakem LE
agarose for gel electrophoresis, Lonza, 50004), purified using an Accuprep
gel purification kit (Bioneer, Korea), and sequenced (Solgent, Korea).
Generation of transgenic fly lines
The corrected Top2 cDNA described above was used to generate pUAST-
Top2. Transgenic lines (UAS-Top2-1 to UAS-Top2-5) were generated by
BestGene (USA) using P[acman] attP strain; PBac{yellow[+]-attP-3B}VK00002
(BDSC 9723, 2nd chromosome).
Synthesis of double-strand RNA
cDNAs for pBluescript SK(-), Tctp, and Top2 were used as templates to
generate double-strand RNA (dsRNA). Primers were synthesized (Bioneer,
Korea). Primer target sites for Control dsRNA, Tctp dsRNA (same as UAS-Tctp
RNAi described in ref. [3] except that the Xba Ι restriction site was deleted),
and Top2 dsRNA were selected as described [3, 37, 49]. The sequences of
primers are as follows:
Control dsRNA F: TAATACGACTCACTATAGG ATCGATAAGCTTGATATCGAATTC
Control dsRNA R:
TAATACGACTCACTATAGG GCACCGCCTACATACCTCGCTCTG
Tctp dsRNA F: TAATACGACTCACTATAGG TGTTTGCCGACACCTACAAG
Tctp dsRNA R: TAATACGACTCACTATAGG CCGTCGCAGTCCATAGATTC
Top2 dsRNA F: TAATACGACTCACTATAGGG TTTGCCAGAGCGATATCTC
Top2 dsRNA R: TAATACGACTCACTATAGGG CCATAGTGGCTCGATCTTTT
In vitro transcription was carried out with dsRNA templates using EZ™ T7
High Yield In Vitro Transcription Kit (Enzynomics, EZ027S) at 37 °C
overnight. Next, the RNA mixtures were treated with DNase Ι (Amplification
grade, Thermo Fisher Scientific, 18068015) for 30min at 37 °C. Samples
were purified using phenol-chloroform isoamyl alcohol mixture (Sigma,
77619), and kept at −80 °C. In total, 30 µg dsRNA was transfected into S2
cells and incubated at 24 °C. dsRNA transfection was performed using the
protocol of the Drosophila RNAi screening center (DRSC) at Harvard
medical school.
Real-Time PCR
Drosophila S2 cells were harvested after 4 days of treatment with dsRNA.
Total RNA was extracted using TRIzol (Invitrogen, 15596026) following the
manufacturer’s instructions. cDNA synthesis and the removal of genomic
DNA (gDNA) were carried out using PrimeScript RT Reagent Kit with gDNA
Eraser (Takara, RR047A). Real-time PCR experiments were conducted in
triplicates or quadruplicates and analyzed using a C1000 TouchTM Thermal
Cycler (Bio-Rad, USA), CFX96TM Real-Time system (Bio-RAD, USA) with
QuantiNova SYBR Green PCR Kit (Qiagen, 208054). PCR reactions were
initially incubated at 50 °C for 10min, followed by denaturation for 15min
at 95 °C. After the pre-treatment, reactions were subjected to the following
thermal cycling conditions: 40 cycles of denaturation at 95 °C for 15 s and
annealing at 55 °C for 30 s with an extension at 72 °C for 30 s. After cycling,
melting curve analyses were performed to check the existence of non-
specific amplification and primer-dimers formation. Experiments were
repeated 3 times using independently cultivated cells. All primers were
purified with the Bio-RP scale and synthesized (Bioneer, Korea). Following
primers with high primer efficiency (>90%) were used for amplification:
GAPDH1 F: CCACTGCCGAGGAGGTCAACTAC
GAPDH1 R: ATGCTCAGGGTGATTGCGTATGC
Tctp #1 F: GTTTCGCAGTGTTCCCGGTC
Tctp #1 R: TGGTGATTGGCTTGTCGGGA
Tctp #2 F: GGTCGTTTCGCAGTGTTCCC
Tctp #2 R: ATTGGCTTGTCGGGAGTCGG
Top2 #1 F: ACGGATACGGAGCGAAGC
Top2 #1 R: GAAGTCCTTGATCTGCACATC
Top2 #2 F: GCTTCACCGTTGAGACTGC
Top2 #2 R: GAAGTCCTTGATCTGCACATC
Quantification and statistical analysis
Wing and eye sizes were measured using the Image J program (NIH, USA).
Wing, eye, and pupa images were taken from representative samples with
average size. Statistical analysis of phenotypes was performed using Prism
8 (GraphPad, USA). ‘n’ is the number of wings (or eyes) used to measure
wing size. Sample mean (x ̅) and sample standard deviation (s) were used
when samples were selected from a population. ‘n’, ‘x̅’, and ‘s’ are similarly
used in all Figures. Population mean (m) and population standard
deviation (σ) were used when samples were not selected. We used an
D.-W. Yang et al.
2













unpaired two-tailed student t-test with standard deviation (SD). If the SD of
the two groups were significantly different based on F-test, we used
Welch’s correction. Significance was defined by the rule of Graph pad
program, n.s., not significant (P > 0.05), *P < 0.05, **P < 0.01, ***P < 0.001,
and ****P < 0.0001. Stacked column graphs were made by Prism 8
(GraphPad, USA). Graph values were adjusted by using the fraction of the
total analysis tool available in Prism 8.
RESULTS
Knockdown of Top2 causes reduced wing growth
To characterize the role of Top2 in imaginal disc development, we
used tissue-specific knockdown by RNAi using the GAL4-UAS
method [50]. For Top2 knockdown, several Top2 RNAi lines that
target the coding strand of Top2 gene were utilized [51].
First, engrailed-GAL4 (en-GAL4) was used to express Top2 RNAi in
the posterior compartment of the wing disc (‘en > Top2 RNAi’ in
short). Knockdown of Top2 by three RNAi lines (Top2 iGD4570, Top2
iVSH330177, and Top2 i10223R-2) led to pupal lethality in both males
and females at 25 °C. In contrast, en > Top2 iJF01300 flies were viable
and showed growth defects in the wing. At 25 °C, female wings
were slightly reduced (5.5 ± 3.1%) (Fig. 1A, B, E). In particular, the
region between L4 and L5 in the posterior domain was
significantly reduced with the near-complete loss of the posterior
crossvein (PCV) (Fig. 1B’). Interestingly, such wing defects were
more pronounced in male wings (15 ± 9.2% reduction) (Fig. 1D)
where the L4 vein was lost or fused with L5 due to loss of tissue
between the two veins (Fig. 1C, D’, F). In most wings, the L5 vein
was considerably thickened in the distal region (Fig. 1D’). At 29 °C,
female wings showed more severe wing size reduction (17.4 ±
5.1%) (Fig. S1B) with loss of L4 and PCV (Fig. S1A, B’, E) which were
comparable to the male wing phenotypes at 25 °C (Fig. 1C, D, D’,
F). Male wings were reduced to 27.4 ± 5.2% of the wild-type size at
29 °C (Fig. S1C, D, F) with a similar loss of L4 (Fig. S1D’). These
results indicate that Top2 is required for normal growth and
differentiation of the wing. Next, we examined wing imaginal discs
from third instar larvae to detect the developmental effects of
Top2 RNAi. In control normal wing disc (en > GFP/+), most nuclei
stained with DAPI were evenly distributed in the wing pouch (Fig.
2A’, B’). In contrast, wing discs with Top2 RNAi showed basal
mislocalization of many cell nuclei in the posterior domain (Fig.
2D’). This suggested that Top2 RNAi causes cell death, resulting in
the basal accumulation of dying cell nuclei. Immunostaining with
anti-cleaved Death Caspase-1 (Dcp-1) showed no obvious Dcp-1
staining in wild-type wing discs (Fig. 2B’’). In contrast, wing discs
with Top2 RNAi had high levels of Dcp-1 staining in the basal
region (Fig. 2D”) where fallen nuclei were accumulated (Fig. 2D’).
Hence, Top2 is essential for preventing cell death during wing
development.
Top2 knockdown leads to defective eye and head formation
We examined whether Top2 knockdown causes similar growth
defects in the eye. We used eyeless–GAL4 (ey-GAL4) to express
Top2 RNAi in early eye imaginal disc prior to retinal differentiation.
Three Top2 RNAi lines (Top2 iGD4570, Top2 iVSH330177, and Top2
RNAi10223R-2) resulted in nearly 100% pupal lethality at 25 °C. Dead
pupae from these RNAi lines showed loss of eyes and severe
disruption of head structures (Fig. 3B–D).
In contrast, about 32% of ey > Top2 RNAiJF01300 flies (N= 159)
survived to adulthood while the rest died as late pupae. The
majority (92%) of these adult flies were females, suggesting that
most males could not survive to adulthood. Dead male pupae lost
most eye/head structures similar to the phenotype shown in Fig.
3B–D. All surviving female adult flies lost their eyes entirely (Fig.
3F) or showed variable size reduction (Fig. 3G–I). Hence, Top2 is
required for the development of the eye and head, and loss of
Top2 is more critical for the survival of males than females.
Fig. 1 Knockdown of Top2 causes reduced wing growth. A, B Knockdown of Top2 reduces wing size in females. The A/P boundary is
indicated by a dashed line. PCV and ACV are posterior and anterior crossvein, respectively. L2-L5 are longitudinal veins. (A) en > GFP/+ (n= 12,
x̅ ± s= 1 ± 0.039), (B’) en > GFP > Top2 RNAiJF01300 (n= 12, x̅ ± s= 0.945 ± 0.031). Scale bars are 300 µm. (B′) An enlarged view of (B). Knockdown
of Top2 shows defects in the region between L3 and L5 veins in the female wing. (C, D) Knockdown of Top2 reduces wing in male. (C) en >
GFP/+ (n= 12, x ̅ ± s= 1 ± 0.039), (D) en > GFP > Top2 RNAiJF01300 (n= 13, x̅ ± s= 0.850 ± 0.092). (D′) An enlarged view of (D). Knockdown of
Top2 shows loss of wing area including L4 in males. The distal region of L4 and 5 veins are thicker than normal. (E) Quantification of relative
wing sizes in (A, B). (F) Quantification of relative wing sizes in (C, D). Statistical analysis in E, F by unpaired two-tailed student t-test, ***P <
0.001, ****P < 0.0001. Error bars in (E, F) are SD. Scale bars are 300 μm (A, C) and 100 μm (B′, D′).
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Top2 shows synergistic genetic interaction with Tctp in organ
growth in females
Since Tctp and Top2 are essential for organ growth, we tested
whether Tctp and Top2 are functionally related by using an ey >
Tctp RNAi condition that causes a mild reduction of the eye size at
25 °C (Fig. 4C). As shown in Fig. 3F-I, ey > Top2 RNAiJF01300 resulted
in variable eye reduction including complete loss of the eye in
female adult flies. Double knockdown of both Tctp and Top2 led
to pupal lethality in females. Since Tctp RNAi or Top2 RNAiJF01300
did not cause significant pupal lethality in females, Tctp and Top2
seem to synergistically interact in the double RNAi condition.
We also tested their genetic interaction in males. Since ey >
Top2 RNAi caused pupal lethality in males, we used Top2Suo1/+
heterozygous mutant that has slightly smaller eyes (6.2 ± 5.1%)
than male control (Fig. S2A, B, E). Although Top2Suo1/+ did not
significantly enhance the male eye phenotype of Tctp RNAi (Fig.
S2A-E), it enhanced Tctp RNAi eye phenotypes in females (Fig. 4A-
E). About 31.3 ± 6% eye size reduction by Tctp RNAi was further
reduced to 43.1 ± 6.9% by Top2Suo1/+ (Fig. 4A-E). In addition to the
enhanced eye size reduction, Top2Suo1/+ caused more roughness
in the eyes of Tctp RNAi in females (Fig. 4D).
Next, we tested genetic interaction between Tctp and Top2 in
the wing. Top2Suo1/+ flies showed normal wings (Fig. 4F, G, J, K).
Wing defects were divided into weak reduction, intermediate
reduction (Fig. 4H, L), and strong phenotype with more reduction
and severe folding (Fig. 4I, M). All of nub > Tctp RNAi wings were
significantly reduced, showing the intermediate phenotype or the
strong phenotype (Fig. 4N, O). Double knockdown of Top2 and
Tctp showed strongly enhanced wing phenotypes in both sexes
(Fig. S2F-M). Because both Tctp RNAi and Top2 RNAi cause wing
Fig. 2 Top2 RNAi increases cell death. A–B’’’ en > GFP/+ shows no change in the DAPI and Dcp-1 staining in the posterior region at 29 °C. A–
A’’’ Apical section. B-B’’’ Basal section. Staining for GFP, DAPI, and Dcp-1 is as indicated in each panel. Yellow dotted lines in (A’–D’’) indicate the
A/P boundary. Scale bars in (A–D) are 50 µm. a anterior, p posterior. C–D’’’ en > GFP > Top2 RNAiJF01300 shows increased Dcp-1 staining in the
posterior region at 29 °C (3/3 discs; 100%). C–C’’’ Apical section. Dcp-1 staining is weakly increased (White arrow) (C”). D–D’’’ Basal section. Dcp-
1 staining is strongly increased (White arrow in D"). DAPI staining is decreased (White arrow) in the posterior apical region (C’) while it is
accumulated (White arrow) in the posterior basal region (D’).
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defects, we used Top2Suo1/+, which does not affect the wing (Fig.
4G, K), to test whether the genetic interaction between Tctp and
Top2 is synergistic. Top2Suo1/+ showed a weak enhancement of
the Tctp RNAi wing phenotype in males but considerably
increased the frequency of strong wing phenotypes in females
(Fig. 4F-O). These results support a synergistic genetic interaction
of Top2 with Tctp in the females.
Tctp knockdown reduces Top2 protein levels
Based on the enhancement of Top2 RNAi phenotypes by Tctp RNAi,
Tctp may be involved in the regulation of Top2 function. Hence,
we examined whether Top2 levels are affected by Tctp in the wing
disc. Immunostaining with anti-Top2 antibody showed nuclear
localization of Top2 in all wing disc cells (Fig. S3A’). Top2 RNAi
driven by en-GAL4 strongly reduced Top2 staining in the posterior
domain of wing disc, confirming the specificity of the anti-Top2
antibody (Fig. S3B’). However, the region near the anterior-
posterior (A/P) boundary was not effectively knocked down by
Top2 RNAi.
In wing discs with Tctp knockdown by en-GAL4, the posterior
region was reduced compared to the anterior region (Fig. 5B–B’’’).
Top2 levels were weakly reduced in the posterior region in about
79% of the sample (11/14 discs) (Fig. 5B’’). The reduced Top2 levels
in the nuclei of the posterior domain may be related to cell death.
Hence, we tested whether inhibition of cell death by Death-
associated inhibitor of apoptosis 1 (Diap1) might affect Top2
levels. Diap1 overexpression by en-GAL4 in the wild-type back-
ground did not significantly alter the level of Top2 in the posterior
compartment (Fig. 5C–C’’’). However, Top2 reduction was seen in
only 25% of the samples (3/12 discs) when Diap1 was over-
expressed in the Tctp-depleted posterior region, indicating a
partial recovery of the Top2 level (Fig. 5D–D’’’). These results
suggest that Top2 reduction by Tctp RNAi is at least in part due to
cell death.
In a converse experiment, Top2 knockdown by en-GAL4 caused
a local reduction of Tctp levels in the posterior compartment in
100% of discs examined (8/8 discs) (Fig. S4B–B’’’). With Diap1
overexpression, however, only 17% (1/6 discs) of the Top2-
depleted wing discs showed Tctp reduction (Fig. S4D–D’’’). Hence,
Tctp reduction by Top2 RNAi is also related to the caspase
activation.
We also tested whether Tctp RNAi affects Top2 levels and vice
versa in S2 cells. Cells treated with Tctp RNAi showed a decrease in
Top2 protein level (Fig. 5E). These data suggest that Tctp is
required to maintain normal Top2 levels. In addition, Top2 RNAi
resulted in reduced Tctp levels (Fig. 5F). Taken together, Tctp and
Top2 levels are dependent on each other.
Next, we checked whether Tctp RNAi affects the level of Top2 at
the transcriptional level by Real-time PCR in S2 cells. Our data
indicate that about 87% knockdown of Tctp has no significant
effect on the Top2 mRNA level. Likewise, a similar knockdown of
Top2 did not obviously reduce the Tctp mRNA level (Fig. S5).
Hence, the mutual regulation between Tctp and Top2 is likely to
occur at the post-transcriptional level.
Top2 overexpression impairs organ growth
Our data thus far indicate that Top2 is required for the proper
growth of organs. To test whether Top2 overexpression can
promote organ growth, we used a transgenic line overexpressing
Top2. Top2 overexpression by en-GAL4 was confirmed by a strong
enhancement of Top2 immunostaining in the posterior wing disc
(Fig. S6A’, B’). Interestingly, Top2 overexpression at 25 °C resulted
in a reduction of wing size in males (21.3 ± 7.4%) (Fig. S6C–E) and
females (11.9 ± 6.0%) (Fig. S6F–H). We also checked whether Top2
overexpression can impair eye development. Top2 overexpression
by ey-GAL4 resulted in weakly reduced eyes (Fig. S6I–N).
In contrast to relatively weak phenotypes of Top2 overexpres-
sion driven by en-GAL4 or ey-GAL4, we found more severe wing
growth defects by Top2 overexpression in the entire wing region
by nub-GAL4 (Fig. S7A–H). Both females and males of nub > Top2-1
died at 29 °C. To further support the effects of Top2 over-
expression, we tested four additional independent UAS-Top2
transgenic lines. All UAS-Top2 lines were generated using PhiC31
transgenesis for targeted insertion of UAS-Top2 at the same
Fig. 3 Knockdown of Top2 causes defects in eye and head development. A–D Knockdown of Top2 in females by three strong RNAi lines
using ey-GAL4 causes pupal lethality at 25 °C. A ey/+ control. B–D Phenotypes in the head regions from dead pupae. B ey > Top2 RNAiGD4570.
100% late pupal lethality (N= 52). C ey > Top2 RNAiVSH330177. 100% late pupal lethality (N= 46). (D) ey > Top2 RNAi10223R-2. 94.2% late pupal
lethality (N= 52) (All three escapers are females). Scale bars in (A) and (E) are 150 µm. Note that depletion of Top2 in male eye discs by four
different RNAi lines (B–D and Top2 RNAiJF01300) causes pupal lethality with similar defects in the head. F–I Variable eye phenotypes of ey > Top2
RNAiJF01300 adult females. E ey/+ control. F no eye (8%, N= 50), (G) Strong reduction (4%), (H) Intermediate reduction (26%), (I) Mild reduction
(62%). N number of animals.
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Fig. 4 Top2 shows genetic interaction with Tctp in organ growth. A–D Top2Suo1/+ enhances Tctp RNAi eye phenotype in females. A ey/+ (n
= 10, x ̅ ± s= 1 ± 0.05), (B) Top2Suo1/+ (n= 10, x̅ ± s= 0.933 ± 0.034), (C) ey > Tctp RNAi/+ (n= 10, x̅ ± s= 0.687 ± 0.06), (D) ey > Tctp RNAi/Top2Suo1
(n= 8, x ̅ ± s= 0.569 ± 0.069). Scale bar in (A) is150 µm. E Quantification of relative eye sizes in (A–D). Statistical analysis in E by unpaired two-
tailed student t-test, **P < 0.01 and ****P < 0.0001. Error bars in (E) are SD. F–MWing phenotypes of Tctp RNAi and Top2Suo1/+ in males (F–I) and
females (J–M). F, J nub/+ control, (G, K) Top2Suo1/+, H, L Intermediate phenotype showing wing size reduction, (I, M) Strong phenotype
showing size reduction with severe folding. Scale bars in (F), (J) are 300 µm. N, O Genetic interaction between Tctp RNAi and Top2Suo1/+ in
males (N) and females (O). Top2Suo1/+ weakly enhances the intermediate phenotype to the strong phenotype in males (N) while strongly
enhancing it in females (O). N number of animals.
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Fig. 5 Tctp RNAi reduces Top2 protein levels. A–A’’’ en > GFP/+ shows no significant change in the Top2 level in the posterior domain at
25 °C. A GFP, (A’) DAPI, (A’’) Top2, (A’’’) Merge. Scale bars in (A–D) are 50 µm. B-B’’’ en > GFP > Tctp i shows a decrease in Top2 level at 25 °C. (11/
14 discs; 78.6%) (B) GFP, (B’) DAPI, (B’’) Top2, (B’’’) Merge. The white arrow shows an area of decreased Top2 in the posterior region. C–C’’’ en >
GFP > Diap1 shows little change in the Top2 level at 25 °C. (C) GFP, (C’) DAPI, (C’’) Top2, (C’’’) Merge. D–D’’’ en > GFP > Tctp i > Diap1 shows rescue
of Top2 level at 25 °C (8/12 discs; 75%). D GFP, (D’) DAPI, (D’’) Top2, (D’’’) Merge. E, FWestern blots stained for Top2, Tctp, and β-Tubulin. (E) Top2
protein level is decreased in Tctp-depleted S2 cells (representative of three independent experiments). F Tctp protein level is decreased in
Top2-depleted S2 cells (representative of three independent experiments).
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genomic site (28E7 on the second chromosome). 47–75% of
female flies overexpressing Top2 showed strong defects with size
reduction and wrinkling (Fig. S7G). The wings of the remaining
flies were nearly normal. In males, 78–92% of flies showed similar
reduction and wrinkling in the wing (Fig. S7H). The reduction of
organ size by either knockdown or overexpression of Top2
suggests that proper regulation of its level is required for the
normal growth of organs.
Top2 overexpression can partially rescue Tctp RNAi phenotype
We have shown synergistic enhancement of wing phenotypes
when loss-of-function conditions for Tctp and Top2 are combined
(Fig. 4O). For further characterization of the relationship between
these two genes, we tested genetic interaction between Tctp RNAi
and Top2 gain-of-function. Because Top2 overexpression itself
impairs wing development (Fig. S7A–H), it may additively enhance
the Tctp RNAi phenotype. However, since Tctp RNAi causes a
reduction in the Top2 level (Fig. 5B-B’’’, E), a proper level of Top2
overexpression may also lead to rescue of Tctp RNAi phenotype.
To test this possibility, we examined whether the wing
phenotypes of Tctp RNAi shown in Fig. 4H, I, L, and M can be
suppressed to near normal wings by Top2 overexpression. In a
control cross, nub > Tctp RNAi/+ progeny showed 100% penetra-
tion of the wing defects in both sexes. Top2 overexpression from
three of five UAS-Top2 lines (1, 2, and 4) led to suppression of the
Tctp RNAi phenotype in approximately 12–37% female wings
examined (Fig. 6A). In male wings, the suppression was found in
approximately 25–53% of wings from all five UAS-Top2 lines (Fig.
6B). Because the rate of suppression was higher in males, we
tested whether Top2 overexpression might differentially affect the
level of Tctp in a sex-dependent manner. However, Tctp levels
were not noticeably altered in male or female wing discs by Top2
overexpression (Fig. S8A–D’’’) suggesting that the difference is
probably not due to sex-specific regulation of Tctp levels by Top2.
DISCUSSION
In this study, we provided evidence for a positive functional
relationship between Tctp and Top2 in Drosophila organ develop-
ment. Our data show that the targeted knockdown of Top2 in
imaginal discs causes apoptosis and disrupts organ development.
Interestingly, Top2 RNAi organ phenotypes and lethality are
influenced by sex. In Drosophila, dosage compensation of the
male X chromosome is mediated by the Male-specific lethal (MSL)
complex [52–55]. It has been shown that Top2 is recruited to the
MSL complex to enhance the transcription level of X-linked genes
[44]. Hence, the stronger Top2 RNAi phenotypes in males may be
related to defective dosage compensation in males.
Fig. 6 Overexpression of Top2 can partially suppress the Tctp RNAi phenotype. A, B Genetic interaction between Tctp RNAi and Top2
overexpression by UAS-Top2 lines (UAS-Top2-1 to UAS-Top2-5). A Females. Control progeny (nub > Tctp i/+) from a cross between nub > Tctp
RNAi and w1118 flies shows 100% wing defects with no suppression. Tctp RNAi phenotypes are suppressed by Top2 overexpression from three
out of five UAS-Top2 lines (lines 2, 3, and 5) (B) Males. Control progeny (nub > Tctp i/+) shows 100% wing defects with no suppression. Tctp RNAi
phenotypes are suppressed by Top2 overexpression from all five UAS-Top2 lines. N number of animals. Numbers in the bars indicate % adults
showing the suppression.
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Our data show that Tctp RNAi phenotypes are strongly
enhanced in female Top2Suo1/+ heterozygotes, implying a
synergistic genetic interaction between the two genes. In
addition, Tctp RNAi reduces the level of Top2 in developing wing
discs. Similarly, Top2 RNAi leads to a reduction of Tctp levels in
wing discs. Significant numbers of Tctp- or Top2-depleted cells are
probably lost during wing development based on the reduced
size of adult wings. Our data show that overexpression of Diap1
partially suppresses the reduction of Tctp/Top2 levels in wing
discs. Hence, the decreased protein levels in the targeted region of
the wing disc might be in part due to cell death signaling, albeit
not necessarily due to an absence of cells at the 3rd instar larval
stage. In S2 cells, Tctp RNAi also reduces Top2 levels and vice versa,
despite the presence of normal levels of β-Tubulin. Hence, the
altered levels of Tctp and Top2 may not be entirely due to cell
death. It is currently unknown how Tctp and Top2 affect their
levels. One possibility is that Tctp may be involved in transcrip-
tional activation of the Top2 gene because Tctp plays a role in
gene regulation by directly interacting with Brahma (Brm)/Swi/
SNF chromatin remodeler [39]. However, our real-time PCR data
(Fig. S5) suggest that the mutual regulation between Tctp and
Top2 is not at the transcriptional level. Since human TCTP and
TOP2 physically interact, Tctp and Top2 may post-transcriptionally
regulate their protein stability by forming a complex.
Interestingly, we noticed that the Top2 level was not affected by
Top2 RNAi (Fig. S3B’) in the region near the anterior-posterior (A/P)
boundary. This phenomenon is not due to a defect in the en-GAL4
driver because the GFP reporter for en-GAL4 was correctly induced
in the entire posterior domain, including the boundary region (Fig.
S3B). However, the A/P boundary region may be influenced by a
non-autonomous effect from the anterior compartment or by an
unknown feedback mechanism to compensate for the loss
of Top2.
We have shown that either reduction or overexpression of Top2
causes severe growth defects in the wing. This suggests that Top2
protein must be maintained at an optimal level for proper control
of organ growth. Mammalian TOP2 is known to be required for the
survival of proliferating cells by generating transient DNA strand
breaks in various DNA processes, but it is also potentially cytotoxic
because the accumulation of breaks can cause DNA aberrations
such as translocation, leading to apoptosis [56]. Hence, the
observed defects in organ growth by Top2 overexpression may be
due to excessive DNA damages.
An important question is whether the regulation of the Top2
level by Tctp is functionally significant. To address this question,
we checked whether Top2 overexpression can suppress the Tctp
RNAi phenotype by overriding the loss of Top2. Indeed, a
significant fraction of the flies tested shows suppression of the
Tctp RNAi wing phenotype under the Top2 overexpression
condition (Fig. 6A, B), implying a physiological role of the Tctp-
dependent regulation of Top2 levels. Although the suppression of
the Tctp RNAi phenotype by Top2 overexpression is seen in both
sexes, male flies show higher rates of suppression than females.
Top2 overexpression has no significant effects on Tctp levels in
wing discs of either males or females (Fig. S8A-D’’’). Hence, sex-
dependent effects of Top2 overexpression are probably not due to
differential regulation of Tctp levels in males and females. Further
studies are necessary to understand the basis for sex-dependent
effects of Top2. Since Tctp and Top2 are evolutionarily conserved
proteins, it would also be interesting to see whether mammalian
TCTP and TOP2 are mutually regulated to maintain their levels in
developing tissues and organs as seen in Drosophila.
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